Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Procella Therapeutics Logo
Procella Therapeutics CB Rank
628683
Heat Score
45
Procella Therapeutics is an early stage biotechnology company focused on developing cardiac stem cell technology.
Founded
obfuscation
Private Tullinge, Stockholms Lan, Sweden11-50 procella.se
Biotechnology
Therapeutics
Overview

Procella Therapeutics
Heat Score
45

Growth Score
pts
in past quarter
Heat Score 45
-25 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Procella Therapeutics

CB Rank
628683
Procella Therapeutics is an early stage biotechnology company focused on developing cardiac stem cell technology.
Founded
obfuscation
Private Tullinge, Stockholms Lan, Sweden11-50 procella.se
Biotechnology
Therapeutics

Key People

Details

Sub-Organization of 
SmartCella Logo
SmartCella
Operating Status Active
Company Type For Profit
About the Company
Procella Therapeutics is an early stage biotechnology company that develop a cardiac stem cell therapy for patients with advanced heart failure.
Contact Email info@procella.se
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PROC-001
A cardiac progenitor cell technology designed to regenerate muscle in damaged hearts, currently being optimized for manufacturing and quality, with plans for First-in-Human studies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 8

Employee Profiles

News

News and Press

News•Jun 30, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

156

Active Website Tech Count

2Procella Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m.

Total IP

15The intellectual property of Procella Therapeutics includes 11 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Procella Therapeutics has registered 4 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Procella Therapeutics's headquarters? Procella Therapeutics is located in Tullinge, Stockholms Lan, Sweden.Who are Procella Therapeutics's competitors? Alternatives and possible competitors to Procella Therapeutics may include Capricor Therapeutics, BlueRock Therapeutics, and  CellProthera.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|